Healthcare Innovation July 21, 2022
David Raths

PhRMA is working with three top medical schools to assess barriers to clinical trial participation and identify tangible actions and goals that can make a difference

The Pharmaceutical Research and Manufacturers of America (PhRMA) is partnering with three leading medical schools on an initiative to enhance diversity in clinical trials.

PhRMA said it is joining with Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center at Morehouse School of Medicine, and Vanderbilt University Medical Center on an initiative called Equitable Breakthroughs in Medicine Development.

Funded by a grant from PhRMA, the initiative will pilot a network of connected, community-based trial sites that brings together diverse communities, clinical trial sponsors, patients, providers, health partners,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Equity/SDOH, Healthcare System, Pharma, Pharma / Biotech, Trends
LabConnect Agrees to Acquire A4P Consulting
Q&A: Bring your own device: How patients own tech is being used in clinical trials
With $75m cash injection, SynOx plans ph3 rare tumour trial
Outsourcing in Clinical Trials Europe 2024: How technology can continue to propel the clinical trial landscape
FDA Proposes the Establishment of the Center for Clinical Trial Innovation

Share This Article